$NTRB
NutriBand Inc.

2024 Q3 Form 10-Q Financial Statement

#000121390024075159 Filed on September 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q1
Revenue $442.8K $524.6K
YoY Change -32.49% -0.56%
Cost Of Revenue $341.3K $343.4K
YoY Change -4.21% -13.75%
Gross Profit $101.6K $181.2K
YoY Change -66.11% 40.05%
Gross Profit Margin 22.93% 34.54%
Selling, General & Admin $737.3K $924.2K
YoY Change 8.63% -22.32%
% of Gross Profit 726.01% 509.99%
Research & Development $774.0K $563.4K
YoY Change 73.88% 90.44%
% of Gross Profit 762.1% 310.88%
Depreciation & Amortization $69.95K $69.32K
YoY Change -7.12% -6.59%
% of Gross Profit 68.88% 38.25%
Operating Expenses $1.511M $1.488M
YoY Change 34.47% 0.13%
Operating Profit -$1.410M -$1.306M
YoY Change 71.05% -3.68%
Interest Expense $72.31K -$20.19K
YoY Change 683.0% -578.44%
% of Operating Profit
Other Income/Expense, Net -$295.7K
YoY Change 5832.26%
Pretax Income -$1.705M -$1.881M
YoY Change 105.68% 12.01%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.705M -$1.881M
YoY Change 105.68% 12.01%
Net Earnings / Revenue -385.13% -358.55%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$0.15 -$0.23
COMMON SHARES
Basic Shares Outstanding 11.06M shares
Diluted Shares Outstanding 11.06M shares

Balance Sheet

Concept 2024 Q3 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.760M $492.9K
YoY Change 189.56% -75.17%
Cash & Equivalents $6.760M $492.9K
Short-Term Investments
Other Short-Term Assets $196.2K $211.7K
YoY Change -64.87% -42.16%
Inventory $223.9K $168.6K
Prepaid Expenses $196.2K $211.7K
Receivables $68.01K $148.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.248M $1.022M
YoY Change 121.41% -62.07%
LONG-TERM ASSETS
Property, Plant & Equipment $737.5K $774.9K
YoY Change -8.54% -13.68%
Goodwill $5.022M $5.022M
YoY Change 0.0% 0.0%
Intangibles $667.3K
YoY Change -14.5%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.386M $6.495M
YoY Change -3.23% -3.95%
TOTAL ASSETS
Total Short-Term Assets $7.248M $1.022M
Total Long-Term Assets $6.386M $6.495M
Total Assets $13.63M $7.517M
YoY Change 38.1% -20.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $778.8K $680.1K
YoY Change 56.78% 27.2%
Accrued Expenses $17.53K $34.28K
YoY Change -46.47% 9.56%
Deferred Revenue $179.6K $157.5K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $127.7K $127.2K
YoY Change 0.75% 544.28%
Total Short-Term Liabilities $1.104M $999.1K
YoY Change 26.25% 33.46%
LONG-TERM LIABILITIES
Long-Term Debt $69.13K $79.83K
YoY Change -96.69% -20.57%
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $69.13K $79.83K
YoY Change -96.72% -40.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.104M $999.1K
Total Long-Term Liabilities $69.13K $79.83K
Total Liabilities $1.173M $1.079M
YoY Change -60.67% 22.13%
SHAREHOLDERS EQUITY
Retained Earnings -$31.58M -$27.98M
YoY Change 29.76% 24.38%
Common Stock $11.10K $8.860K
YoY Change 41.66% 13.11%
Preferred Stock
YoY Change
Treasury Stock (at cost) $32.64K $32.64K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $12.46M $6.438M
YoY Change
Total Liabilities & Shareholders Equity $13.63M $7.517M
YoY Change 38.1% -20.51%

Cashflow Statement

Concept 2024 Q3 2024 Q1
OPERATING ACTIVITIES
Net Income -$1.705M -$1.881M
YoY Change 105.68% 12.01%
Depreciation, Depletion And Amortization $69.95K $69.32K
YoY Change -7.12% -6.59%
Cash From Operating Activities -$1.544M -$718.2K
YoY Change 55.13% -11.77%
INVESTING ACTIVITIES
Capital Expenditures $38.89K $49.16K
YoY Change 390.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$38.89K -$49.16K
YoY Change 390.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.140K -5.030K
YoY Change -100.25% -26.57%
NET CHANGE
Cash From Operating Activities -1.544M -718.2K
Cash From Investing Activities -38.89K -49.16K
Cash From Financing Activities -5.140K -5.030K
Net Change In Cash -1.588M -772.4K
YoY Change -250.29% -7.04%
FREE CASH FLOW
Cash From Operating Activities -$1.544M -$718.2K
Capital Expenditures $38.89K $49.16K
Free Cash Flow -$1.583M -$767.4K
YoY Change 59.04% -6.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10111357 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7833150 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55654
dei Entity Registrant Name
EntityRegistrantName
NUTRIBAND INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1118176
dei Entity Address Address Line1
EntityAddressAddressLine1
121 South Orange Ave.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1500
dei Entity Address City Or Town
EntityAddressCityOrTown
Orlando
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32801
dei City Area Code
CityAreaCode
(407)
dei Local Phone Number
LocalPhoneNumber
377-6695
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11096185 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6759967 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
492942 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68011 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
148649 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
223860 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
168605 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
196235 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
211667 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
7248073 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1021863 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
737534 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
774924 usd
CY2024Q3 us-gaap Goodwill
Goodwill
5021713 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5021713 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15684 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31374 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
610705 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
667280 usd
CY2024Q3 us-gaap Assets
Assets
13633709 usd
CY2024Q1 us-gaap Assets
Assets
7517154 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
778827 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
680132 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
179576 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
157502 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17528 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34276 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
127659 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
127183 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1103590 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
999093 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
69133 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
79826 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1172723 usd
CY2024Q1 us-gaap Liabilities
Liabilities
1078919 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
291666666 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
291666666 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11106185 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8869870 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11096105 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8859870 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
11096 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
8860 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44066396 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34442339 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-304 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-304 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10000 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10000 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
32641 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
32641 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31583561 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27980019 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12460986 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6438235 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13633709 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7517154 usd
CY2024Q3 us-gaap Revenues
Revenues
442830 usd
CY2023Q3 us-gaap Revenues
Revenues
655928 usd
us-gaap Revenues
Revenues
851362 usd
us-gaap Revenues
Revenues
1132860 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
341272 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
356256 usd
us-gaap Cost Of Revenue
CostOfRevenue
585018 usd
us-gaap Cost Of Revenue
CostOfRevenue
610904 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
773975 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
445122 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1748510 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
845552 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
737325 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
678738 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1817053 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1518470 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
1852572 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
1480116 usd
us-gaap Costs And Expenses
CostsAndExpenses
4150581 usd
us-gaap Costs And Expenses
CostsAndExpenses
2974926 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1409742 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-824188 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3299219 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1842066 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
77332 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4250 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
77350 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
10065 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-368036 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-368036 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5019 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
9235 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
13637 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
12401 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-295723 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4985 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-304323 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2336 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1705465 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-829173 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3603542 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1844402 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1705465 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-829173 usd
us-gaap Net Income Loss
NetIncomeLoss
-3603542 usd
us-gaap Net Income Loss
NetIncomeLoss
-1844402 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11061725 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7833150 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10111357 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7833150 shares
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6438235 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
553335 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8400000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
672958 usd
us-gaap Net Income Loss
NetIncomeLoss
-3603542 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12460986 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8572990 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
87090 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
75030 usd
us-gaap Net Income Loss
NetIncomeLoss
-1844402 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
6890708 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
13363113 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
130380 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
672958 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1705465 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
12460986 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7719881 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-829173 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
6890708 usd
us-gaap Net Income Loss
NetIncomeLoss
-3603542 usd
us-gaap Net Income Loss
NetIncomeLoss
-1844402 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
139050 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
150511 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
15690 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
15690 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11837 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-368036 usd
ntrb Stockbased Compensationwarrants
StockbasedCompensationwarrants
87090 usd
us-gaap Share Based Compensation
ShareBasedCompensation
553335 usd
us-gaap Share Based Compensation
ShareBasedCompensation
75030 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-80638 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
122244 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-15432 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
192722 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55255 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-72414 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
22074 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
54987 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16748 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-15289 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
103617 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-37901 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2377673 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1744999 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45085 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2624 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45085 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2624 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2000000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
106528 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8400000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10217 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9792 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8689783 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2096736 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6267025 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
349113 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
492942 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1985440 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6759967 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2334553 usd
us-gaap Interest Paid Net
InterestPaidNet
611 usd
us-gaap Interest Paid Net
InterestPaidNet
2407 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2043 usd
us-gaap Stock Issued1
StockIssued1
672956 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
60 usd
CY2018Q3 ntrb Royalty Percentage
RoyaltyPercentage
0.06 pure
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6759967 usd
ntrb Working Capital
WorkingCapital
6144483 usd
us-gaap Net Income Loss
NetIncomeLoss
-3603542 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2377673 usd
CY2024Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8400000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration:underline">Use of Estimates </span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates including, but not limited to, those related to such items as income tax exposures, accruals, depreciable/useful lives, allowance for doubtful accounts and valuation allowances. The Company bases its estimates on historical experience and on other various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></p>
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
851362 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1132860 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
442830 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
655928 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
851362 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1132860 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
442830 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
655928 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
6461000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
1200 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
11836 usd
CY2024Q3 us-gaap Accounts Receivable Fair Value Disclosure
AccountsReceivableFairValueDisclosure
106528 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
223860 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
46458 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21681 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
155721 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
168605 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
7466 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8707 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
134691 usd
CY2024Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P10Y
CY2024Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
3302478 usd
CY2024Q3 us-gaap Goodwill
Goodwill
5021713 usd
CY2024Q1 us-gaap Goodwill
Goodwill
5021713 usd
CY2024Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
6872833 shares
CY2023Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
1783373 shares
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1501702 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1456617 usd
CY2024Q3 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
764168 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
681693 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
737534 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
774924 usd
us-gaap Depreciation
Depreciation
82475 usd
us-gaap Depreciation
Depreciation
93936 usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
61163 usd
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
72445 usd
CY2022Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
32274 usd
CY2022Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
22795 usd
CY2022Q2 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.0295 pure
CY2023Q3 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
5000000 usd
CY2024Q1 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.07 pure
CY2024Q3 us-gaap Advance Rent
AdvanceRent
300000 usd
CY2024Q2 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
300000 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
300000 usd
CY2023Q3 us-gaap Extinguishment Of Debt Gain Loss Per Share Net Of Tax
ExtinguishmentOfDebtGainLossPerShareNetOfTax
368036
CY2024Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
106528 usd
CY2024Q3 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.10 pure
us-gaap Interest Expense Debt
InterestExpenseDebt
5212 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
12401 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1131500 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1131500 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
520795 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
464220 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
610705 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
667280 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56575 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56575 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
56575 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
113148 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
113148 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
113148 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
94226 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
120460 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
610705 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
390000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
422955 usd
CY2024Q3 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
6420000 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1605000 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3210000 shares
CY2024Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
6.43
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
76230 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
152460 shares
CY2024Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
87500
CY2024Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
60085 shares
CY2023Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
2000000 usd
CY2023Q3 ntrb Purchase Share
PurchaseShare
1 pure
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company effected a one-for-four reverse stock split, pursuant to which each outstanding share of common stock was changed into 0.25 shares of common stock, and the Company decreased its authorized common stock in the same ratio from 100,000,000 to 25,000,000 shares.
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
10000 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
32641 usd
CY2024Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
8400000 usd
CY2024Q2 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
2 shares
CY2024Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
CY2024Q2 us-gaap Line Of Credit Facility Increase Accrued Interest
LineOfCreditFacilityIncreaseAccruedInterest
4922 usd
CY2024Q2 us-gaap Investment Company Issuance Of Shares Per Share
InvestmentCompanyIssuanceOfSharesPerShare
76230
CY2024Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
152460 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
87500 shares
us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
10000 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
32641 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y6M
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.4505 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0445 pure
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
390145 usd
CY2024Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
60085 shares
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
408333 shares
CY2022Q1 ntrb Additional Shares Reserved
AdditionalSharesReserved
233333 shares
CY2023Q1 ntrb Additional Shares Reserved
AdditionalSharesReserved
233333 shares
CY2021Q4 ntrb Common Stock Reserved
CommonStockReserved
408333 shares
CY2024Q1 ntrb Shares Held In Companys Employee Stock Option Plan Before Amendment
SharesHeldInCompanysEmployeeStockOptionPlanBeforeAmendment
875000 shares
CY2024Q1 ntrb Shares Held In Companys Employee Stock Option Plan After Amendment
SharesHeldInCompanysEmployeeStockOptionPlanAfterAmendment
1400000 shares
CY2024Q3 ntrb Balance Shares Issuance Of Options
BalanceSharesIssuanceOfOptions
75166 shares
ntrb Warrant Expiry Term
WarrantExpiryTerm
P3Y
CY2024Q3 us-gaap Fair Value Option Ineligible Items Aggregate Carrying Amount
FairValueOptionIneligibleItemsAggregateCarryingAmount
553335 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y6M
CY2024 ntrb Warrant Expiry Term
WarrantExpiryTerm
P3Y
CY2024Q1 us-gaap Fair Value Option Ineligible Items Aggregate Carrying Amount
FairValueOptionIneligibleItemsAggregateCarryingAmount
499856 usd
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y6M
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
851362 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1132860 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
442830 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
655928 usd
us-gaap Gross Profit
GrossProfit
266344 usd
us-gaap Gross Profit
GrossProfit
521957 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
101558 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
299672 usd
us-gaap Operating Expenses
OperatingExpenses
3565563 usd
us-gaap Operating Expenses
OperatingExpenses
2364022 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1511300 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1123860 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
139050 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
150511 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
69949 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
851362 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1132860 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
442830 usd
CY2024Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
737634 usd
CY2024Q1 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
806423 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
13633709 usd
CY2024Q3 ntrb Annual Salary Received Per Annum
AnnualSalaryReceivedPerAnnum
250000 usd
ntrb Percentage Of Net Income
PercentageOfNetIncome
0.035 pure
CY2022Q3 ntrb Annual Salary Received Per Annum
AnnualSalaryReceivedPerAnnum
150000 usd
ntrb Estimated Cost
EstimatedCost
8100000 usd
us-gaap Other Expenses
OtherExpenses
1080329 usd
CY2022Q1 ntrb Warehouse Space
WarehouseSpace
12000 pure
CY2022Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
106528 usd
CY2024Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
118675 usd
us-gaap Legal Fees
LegalFees
500000 usd
CY2024Q3 us-gaap Cash
Cash
1000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11061725 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7833150 shares
ntrb Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
usd
CY2024Q3 ntrb Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
ntrb Stockbased Compensationwarrants
StockbasedCompensationwarrants
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
76010 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
655928 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
9793599 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001676047

Files In Submission

Name View Source Status
0001213900-24-075159-index-headers.html Edgar Link pending
0001213900-24-075159-index.html Edgar Link pending
0001213900-24-075159.txt Edgar Link pending
0001213900-24-075159-xbrl.zip Edgar Link pending
ea0213099-10q_nutriband.htm Edgar Link pending
ea021309901ex31-1_nutriband.htm Edgar Link pending
ea021309901ex31-2_nutriband.htm Edgar Link pending
ea021309901ex32-1_nutriband.htm Edgar Link pending
ea021309901ex32-2_nutriband.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntrb-20240731.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ntrb-20240731_def.xml Edgar Link unprocessable
ntrb-20240731_lab.xml Edgar Link unprocessable
ntrb-20240731_pre.xml Edgar Link unprocessable
ea0213099-10q_nutriband_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ntrb-20240731_cal.xml Edgar Link unprocessable